Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Vitrolife

Vitrolife

Read in Swedish

Barbro Fridén steps down as a member of the board of Vitrolife AB (publ)

19:00 / 18 November 2019 Vitrolife Press release

Barbro Fridén has decided to step down as a member of the board of Vitrolife AB due to other future opportunities. Barbro Fridén has been a member of the board of Vitrolife since 2010. "We thank Barbro Fridén for contributing to Vitrolife's success with great commitment and expertise", says Jón Sigurdsson, chairman of the board.

Gothenburg, November 18, 2019
VITROLIFE AB (publ)

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.

Vitrolife has approximately 400 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com.Website: www.vitrolife.com/

Show as PDF

Show original from Cision

Cision

This information was distributed by Cision http://www.cisionwire.se/